Pfizer planted its flag in South San Francisco in 2022 when it acquired Global Blood Therapeutics for $5.4B. Two years later, ...

Markets have delivered plenty of twists lately, with inflation cooling but growth uneven and volatility still lurking around ...

With the Centers for Disease Control and Prevention estimate 500,000 cases nationwide every year, the race for a vaccine is ...

Pfizer (PFE) stock is in focus as the company plans to close its South San Francisco research site and office by April. Read ...

ROANOKE, Va. (WDBJ) - Pfizer said it plans to seek regulatory approval of a new vaccine for Lyme disease. Vaccines for Lyme ...

A new vaccine to prevent Lyme disease in humans may soon be available. Pfizer said it's planning to seek regulatory approval.

Pfizer's dividend safety hinges on free cash flow recovery in 2026, as the current payout consumes more cash than the company ...

There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot because of a lack of ...

Pfizer and Valneva said on Monday their Lyme disease vaccine showed more ​than 70% efficacy in a late-stage study, even as it ...

Add Yahoo as a preferred source to see more of our stories on Google. Chairman and CEO of Pfizer Albert Bourla attends the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January ...